Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: Results of the PROTECTION AMI randomized controlled trial

European Heart Journal

Volumn 35, Issue 37, 2014, Pages 2516-2523

  Lincoff, A Michael ^a   Roe, Matthew ^b   Aylward, Philip ^c   Galla, John ^a   Rynkiewicz, Andrzej ^d   Guetta, Victor ^e   Zelizko, Michael ^f   Kleiman, Neal ^g   White, Harvey ^h   McErlean, Ellen ^a   Erlinge, David ⁱ   Laine, Mika ^j   Dos Santos Ferreira, Jorge Manuel ^k   Goodman, Shaun ^l   Mehta, Shamir ^m   Atar, Dan ⁿ   Suryapranata, Harry ^o   Jensen, Svend Eggert ^p   Forster, Tamas ^q   Fernandez Ortiz, Antonio ^r   Schoors, Danny ^s   Radke, Peter ^t   Belli, Guido ^u   Brennan, Danielle ^a   Bell, Gregory ^v   Krucoff, Mitchell ^b   more..

^a LERNER RESEARCH INSTITUTE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c FLINDERS UNIVERSITY   (Australia)

^d UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^e SHEBA MEDICAL CENTER   (Israel)

^f INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^g HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^h AUCKLAND CITY HOSPITAL   (New Zealand)

ⁱ LUND UNIVERSITY   (Sweden)

^j HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^k HOSPITAL DE SANTA CRUZ   (Portugal)

^l ST MICHAEL'S HOSPITAL   (Canada)

^m HAMILTON GENERAL HOSPITAL   (Canada)

ⁿ UNIVERSITY OF OSLO   (Norway)

^o RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^p AARHUS UNIVERSITY HOSPITAL   (Denmark)

^q UNIVERSITY OF SZEGED   (Hungary)

^r HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^s UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^t UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^u Unita Operativa di Emodinamica e Cardiologia Invasiva Istitutio Clinico Humanitas   (Italy)

^v UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Myocardial; Myocardial infarction; Pharmacology; Reperfusion; Stents; Stunning

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATINE KINASE MB; DELCASERTIB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; PRASUGREL; PROTEIN KINASE C DELTA; BIOLOGICAL MARKER; PEPTIDE; PROTEIN KINASE INHIBITOR; TROPONIN I;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; ENZYME INHIBITION; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT REFERRAL; PERCUTANEOUS CORONARY INTERVENTION; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ADJUVANT CHEMOTHERAPY; AREA UNDER THE CURVE; CLINICAL TRIAL; DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; PILOT STUDY; PROCEDURES; TREATMENT OUTCOME;

AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; CHEMOTHERAPY, ADJUVANT; CREATINE KINASE, MB FORM; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDES; PERCUTANEOUS CORONARY INTERVENTION; PILOT PROJECTS; PROTEIN KINASE INHIBITORS; TREATMENT OUTCOME; TROPONIN I;

EID: 84907396129     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu177     Document Type: Article

References (23)

1. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-322.
2. Dixon S, O'Neill W. Interventions in acute myocardial infarction. Curr Probl Cardiol 2001;26:614-672.
3. APEX AMI Investigators. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention-A randomized controlled trial. J Am Med Assoc 2007;297:43-51.
4. ISIS-4 Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-685.
5. Theroux P, Chaitman BR, Danchin N, Erhardt L, Meinertz T, Schroeder JS, Tognoni G, White HD, Willerson JT, Jessel A. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations: main results of the GUARDIAN trial. Circulation 2000;102:3032-3038.
6. Mehta SY, Yusuf S, Diaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L. CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction the CREATE-ECLA randomized controlled trial. J Am Med Assoc 2005;293:437-446.
7. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007;357: 1121-1135.
8. Chen L.Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and varepsilon PKC. Proc Natl Acad Sci USA 2001;98:11114-11119.
9. Ikeno F, Inagaki K, Rezaee M, Mochlyrosen D. Impaired perfusion after myocardial infarction is due to reperfusion-induced δPKC-mediated myocardial damage. Cardiovasc Res 2007;73:699-709.
10. DELTA MI Investigators. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Circulation 2008;117:886-896.
11. Christenson R, Vollmer R, Ohman E, Peck S, Thompson T, Duh S, Ellis S, Newby L, Topol E, Califf R. TAMI Study Group. Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. Am J Cardiol 2000;85:543-547.
12. Piper H, Garcia-Dorado D, Ovize M.A fresh look at reperfusion injury. Cardiovasc Res 1998;38:291-300.
13. Griffiths E, Halestrap A. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 1995;307:93-98.
14. Halestrap AP. What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 2009;46:821-831.
15. Bolli R. Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res 2004;95:125-134.
16. EMIP-FR Group. Effect of 48-h intravenous trimetazidine on short-and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy.Adouble-blind, placebo-controlled, randomized trial. Eur Heart J 2000; 21:872-873.
17. Antman E. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial. Lancet 2002;360:1189-1196.
18. Ross A, Gibbons R, Stone G, Kloner R, Alexander R. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 2005;45: 1775-1780.
19. Csukai M, Mochly-Rosen D. Pharmacologic modulation of protein kinase C isozymes: the role of racks and subcellular localisation. Pharmacol Res 1999;39:253-259.
20. Garcia-Fernandez LF, Losada A, Alcaide V, Alvarez AM, Cuadrado A, Gonzalez L, Nakayama K, Nakayama KI, Fernandez-Sousa JM, Munoz A, Sanchez-Puelles JM. AplidinTM induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase C. Oncogene 2002;21: 7533-7544.
21. Inagaki K. Inhibition of-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation 2003;108:2304-2307.
22. Mochly-Rosen D. Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science 1995;268:247-251.
23. Mochly-Rosen D, Khaner H, Lopez J, Smith B. Intracellular receptors for activated protein kinase C: identification of a binding site for the enzyme. J Biol Chem 1991; 266:14866-14868.